… caught President Xi Jinping and Russian leader Vladimir Putin discussing the … . But in China’s thriving biotech sector, such ambitions are increasingly … national priority, pouring billions into biotech initiatives in an effort to …

… long-standing ties with Moscow. While low commodity prices … India’s objection to genetically modified US agricultural products. India … dependent on supply from Moscow,” the report said. … captured networks that entrench Russian influence,” CSD said. Following …

… on Russian oil giants Rosneft and Lukoil to pressure Moscow into Ukraine peace … effort" to end the Russia-Ukraine war, Orban stated, aligning Budapest … collaborative research in AI and biotechnology was announced, alongside space technology …

De-extinction firm Colossal Biosciences announced Tuesday that it was acquiring animal cloning firm Viagen. The same day, retired NFL all-star Tom Brady had a related announcement of his own. He said that he had cloned his deceased pit bull, Lua, with help …

… cyberattacks. Ukraine accounts for more than 25% of Russia’s … cyber operations, making it Russia’s primary target. Building … sugarcoat the threat environment. Russian state actors have shifted … , and UK biotech startup GutSee Health, Ukraine will become the …

… Education and Science of Ukraine has approved the introduction … -rerector of the State Biotechnological University became the odious … adherence to the "Russian world". Who is … management of the State Biotechnological University and the distribution …

… patients. For reference Ukraine';s Digital Innovation Development … including MedTech (medical technologies), BioTech (biotechnologies), and AI (artificial intelligence). It … , develop infrastructure, integrate Ukraine into the global innovation space, …

… first of its kind and Russia now has a full-cycle … in healthcare services and biotechnologies. For example, Russia’s HPV vaccine production … Associate at BRICS+ Consulting Group  Russian & Middle Eastern Specialist ** MORE …

- Simultaneously published in JAMA Cardiology along with moderated posters at AHA, acoramidis demonstrated: 59% risk reduction in ACM in the ATTR-CM variant population at Month 42 (p=0.032) compared to patients initially randomized to placebo in the …

… Korea, Malaysia, the Philippines, and Russia, with applications pending in other … has already been granted in Russia, with applications pending in the … is as expected, given the biotechnology business model where companies in …